Fc fusion therapeutics

The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis

Medical / /

Since the approval of Enbrel® in 1998 for the treatment of rheumatoid arthritis, Fc fusion therapies have evolved into a prominent class of therapeutics; currently, several therapies are being developed for a variety of disease indications   London   Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list […]

The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis Read More »

The Fc protein and glyco-engineered antibodies market is projected to grow at a CAGR of over 30% during 2021-2030

Health & Fitness / /

With the emergence of blockbuster drugs, such as Gazyva® (for Chronic Lymphocytic Leukemia) and POTELEGIO® (for Sézary syndrome), Fc engineered antibodies have garnered significant interest in the medical community, for various clinical conditions   London   Roots Analysis has announced the addition of “Fc Protein and Glyco-engineered Antibodies Market2021-2030” report to its list of offerings.

The Fc protein and glyco-engineered antibodies market is projected to grow at a CAGR of over 30% during 2021-2030 Read More »